<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38535541</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Lower Limb Paralysis Associated with Chikungunya in Kinshasa, the Democratic Republic of the Congo: Survey Report.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">198</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens13030198</ELocationID><Abstract><AbstractText>Polio-associated paralysis is one of the diseases under national surveillance in the Democratic Republic of the Congo (DRC). Although it has become relatively rare due to control measures, non-polio paralysis cases are still reported and constitute a real problem, especially for etiological diagnosis, which is necessary for better management and response. From September 2022 to April 2023, we investigated acute flaccid paralysis (AFP) cases in Kinshasa following an alert from the Provincial Division of Health. All suspected cases and their close contacts were investigated and sampled. Among the 57 sampled patients, 21 (36.8%) were suspects, and 36 (63.2%) were contacts. We performed several etiological tests available in the laboratory, targeting viruses, including Poliovirus, Influenza virus, SARS-CoV-2, Enterovirus, and arboviruses. No virus material was detected, but the serological test (ELISA) detected antibodies against Chikungunya Virus, i.e., 47.4% (27/57) for IgM and 22.8% (13/57) for IgG. Among suspected cases, we detected 33.3% (7/21) with anti-Chikungunya IgM and 14.3% (3/21) of anti-Chikungunya IgG. These results highlight the importance of enhancing the epidemiological surveillance of Chikungunya.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matungala-Pafubel</LastName><ForeName>Mathy</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulabula-Penge</LastName><ForeName>Junior</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Département de Biologie Médicale, Université Protestante au Congo, Kinshasa 01212, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matondo-Kuamfumu</LastName><ForeName>Meris</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esala</LastName><ForeName>Samy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division Provinciale de la Santé de Kinshasa, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edidi-Atani</LastName><ForeName>François</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pukuta-Simbu</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tshiminyi-Munkamba</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tutu Tshia N'kasar</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Direction de Surveillance Epidémiologique de Kinshasa, Ministère de Santé, Hygiène et Prévention, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katanga</LastName><ForeName>Trésor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division Provinciale de la Santé de Kinshasa, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndomba-Mukanya</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8887-7963</Identifier><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbonga-Mande</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baketana-Kinzonzi</LastName><ForeName>Lionel</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinganda-Lusamaki</LastName><ForeName>Eddy</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9795-0165</Identifier><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukadi-Bamuleka</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6836-8704</Identifier><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mambu-Mbika</LastName><ForeName>Fabrice</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbala-Kingebeni</LastName><ForeName>Placide</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nkwembe-Ngabana</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nkuba-Ndaye</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2850-7498</Identifier><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okitundu-Luwa</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre Neuro-Psycho-Pathologie, Kinshasa H8V3+CJ3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahuka-Mundeke</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa 01204, Democratic Republic of the Congo.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa H8P3+7X3, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Kinshasa</Keyword><Keyword MajorTopicYN="N">chikungunya</Keyword><Keyword MajorTopicYN="N">paralysis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>12</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38535541</ArticleId><ArticleId IdType="pmc">PMC10974750</ArticleId><ArticleId IdType="doi">10.3390/pathogens13030198</ArticleId><ArticleId IdType="pii">pathogens13030198</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaushik R., Kharbanda P., Bhalla A., Rajan R., Prabhakar S. Acute Flaccid Paralysis in Adults: Our Experience. J. Emerg. Trauma Shock. 2014;7:149. doi: 10.4103/0974-2700.136847.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-2700.136847</ArticleId><ArticleId IdType="pmc">PMC4126112</ArticleId><ArticleId IdType="pubmed">25114422</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Dong C., Ubogu E.E. Immunotherapy of Guillain-Barré Syndrome. Hum. Vaccines Immunother. 2018;14:2568–2579. doi: 10.1080/21645515.2018.1493415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1493415</ArticleId><ArticleId IdType="pmc">PMC6314401</ArticleId><ArticleId IdType="pubmed">29953326</ArticleId></ArticleIdList></Reference><Reference><Citation>Conté A., Sawadogo B., Gbamou N., Kouawo M., Yanogo P., Otshadiandjeka J., Camara A., Méda N., Saka B. Profil épidémiologique des paralysies flasques aiguës (PFA) de 2009 à 2018 en Guinée. J. Interv. Epidemiol. Public Health. 2021;4:7. doi: 10.37432/jieph.supp.2021.4.3.03.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.37432/jieph.supp.2021.4.3.03.7</ArticleId></ArticleIdList></Reference><Reference><Citation>Soumahoro M.-K., Boelle P.-Y., Gaüzere B.-A., Atsou K., Pelat C., Lambert B., La Ruche G., Gastellu-Etchegorry M., Renault P., Sarazin M., et al. The Chikungunya Epidemic on La Réunion Island in 2005–2006: A Cost-of-Illness Study. PLoS Negl. Trop. Dis. 2011;5:e1197. doi: 10.1371/journal.pntd.0001197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001197</ArticleId><ArticleId IdType="pmc">PMC3114750</ArticleId><ArticleId IdType="pubmed">21695162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabue J.P., Mushiya F., Pukuta E., Mbaya N., Yogolelo R., Muyamuna E., Kandolo P., Mashako M., Tamfum J.J.M. Surveillance virologique des paralysies flasques aiguës en République démocratique du Congo (RDC) 1997–2001. Méd. Trop. 2004;64:137.</Citation><ArticleIdList><ArticleId IdType="pubmed">15460141</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Department of Immunization, Vaccine and Biologicals . Polio Laboratory Manual. World Health Organization; Geneva, Switzerland: 2004. Immunization, Vaccines and Biologicals.</Citation></Reference><Reference><Citation>CDC . CDC Protocol of Realtime RTPCR for Swine Influenza A (H1N1) CDC; Atlanta, GA, USA: 2009. p. 8.</Citation></Reference><Reference><Citation>Marembo T., Chimbunde P., Chipendo T., Munemo C., Manangazira P., Bangure D. Comparison of Real-Q 2019-nCoV and DaAn Gene 2019-nCoV Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2. J. Clin. Lab. Anal. 2022;36:e24161. doi: 10.1002/jcla.24161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24161</ArticleId><ArticleId IdType="pmc">PMC8761419</ArticleId><ArticleId IdType="pubmed">34882825</ArticleId></ArticleIdList></Reference><Reference><Citation>De Weggheleire A., Nkuba-Ndaye A., Mbala-Kingebeni P., Mariën J., Kindombe-Luzolo E., Ilombe G., Mangala-Sonzi D., Binene-Mbuka G., De Smet B., Vogt F., et al. A Multidisciplinary Investigation of the First Chikungunya Virus Outbreak in Matadi in the Democratic Republic of the Congo. Viruses. 2021;13:1988. doi: 10.3390/v13101988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101988</ArticleId><ArticleId IdType="pmc">PMC8541179</ArticleId><ArticleId IdType="pubmed">34696418</ArticleId></ArticleIdList></Reference><Reference><Citation>Selhorst P., Makiala-Mandanda S., De Smet B., Mariën J., Anthony C., Binene-Mbuka G., De Weggheleire A., Ilombe G., Kinganda-Lusamaki E., Pukuta-Simbu E., et al. Molecular Characterization of Chikungunya Virus during the 2019 Outbreak in the Democratic Republic of the Congo. Emerg. Microbes Infect. 2020;9:1912–1918. doi: 10.1080/22221751.2020.1810135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1810135</ArticleId><ArticleId IdType="pmc">PMC8284967</ArticleId><ArticleId IdType="pubmed">32787529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinganda-Lusamaki E., Black A., Mukadi D.B., Hadfield J., Mbala-Kingebeni P., Pratt C.B., Aziza A., Diagne M.M., White B., Bisento N., et al. Integration of Genomic Sequencing into the Response to the Ebola Virus Outbreak in Nord Kivu, Democratic Republic of the Congo. Nat. Med. 2021;27:710–716. doi: 10.1038/s41591-021-01302-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01302-z</ArticleId><ArticleId IdType="pmc">PMC8549801</ArticleId><ArticleId IdType="pubmed">33846610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinganda-Lusamaki E., Baketana L.K., Ndomba-Mukanya E., Bouillin J., Thaurignac G., Aziza A.A., Luakanda-Ndelemo G., Nuñez N.F., Kalonji-Mukendi T., Pukuta E.S., et al. Use of Mpox Multiplex Serology in the Identification of Cases and Outbreak Investigations in the Democratic Republic of the Congo (DRC) Pathogens. 2023;12:916. doi: 10.3390/pathogens12070916.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12070916</ArticleId><ArticleId IdType="pmc">PMC10385798</ArticleId><ArticleId IdType="pubmed">37513764</ArticleId></ArticleIdList></Reference><Reference><Citation>Twist Bioscience Twist Pan-Viral Panel Confident Identification of over 1000 Viral Human Pathogens from a Single Sample.  [(accessed on 20 May 2022)].  Available online:  https://www.twistbioscience.com/sites/default/files/resources/2021-12/ProductSheet_NGS_PanViralPanel_30NOV21_Rev2.0.pdf)</Citation></Reference><Reference><Citation>Van Doorn P.A., Ruts L., Jacobs B.C. Clinical Features, Pathogenesis, and Treatment of Guillain-Barré Syndrome. Lancet Neurol. 2008;7:939–950. doi: 10.1016/S1474-4422(08)70215-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70215-1</ArticleId><ArticleId IdType="pubmed">18848313</ArticleId></ArticleIdList></Reference><Reference><Citation>Proesmans S., Katshongo F., Milambu J., Fungula B., Muhindo Mavoko H., Ahuka-Mundeke S., Inocêncio Da Luz R., Van Esbroeck M., Ariën K.K., Cnops L., et al. Dengue and Chikungunya among Outpatients with Acute Undifferentiated Fever in Kinshasa, Democratic Republic of Congo: A Cross-Sectional Study. PLoS Negl. Trop. Dis. 2019;13:e0007047. doi: 10.1371/journal.pntd.0007047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007047</ArticleId><ArticleId IdType="pmc">PMC6748445</ArticleId><ArticleId IdType="pubmed">31487279</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyembe-Tamfum J.J., Peyrefitte C.N., Yogolelo R., Mathina Basisya E., Koyange D., Pukuta E., Mashako M., Tolou H., Durand J.P. Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo. Med. Trop. Rev. Corps Sante Colon. 2003;63:637–638.</Citation><ArticleIdList><ArticleId IdType="pubmed">15077435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wat’senga Tezzo F., Fasine S., Manzambi Zola E., Marquetti M.D.C., Binene Mbuka G., Ilombe G., Mundeke Takasongo R., Smitz N., Bisset J.A., Van Bortel W., et al. High Aedes spp. Larval Indices in Kinshasa, Democratic Republic of Congo. Parasit. Vectors. 2021;14:92. doi: 10.1186/s13071-021-04588-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13071-021-04588-7</ArticleId><ArticleId IdType="pmc">PMC7852359</ArticleId><ArticleId IdType="pubmed">33522947</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro T.J., Guimarães L.F., Silva M.T.T., Soares C.N. Neurological Manifestations of Chikungunya and Zika Infections. Arq. Neuro-Psiquiatr. 2016;74:937–943. doi: 10.1590/0004-282x20160138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x20160138</ArticleId><ArticleId IdType="pubmed">27901259</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam Z.  Ph.D. Thesis. Erasmus University Rotterdam; 2010.  [(accessed on 30 November 2023)]. Campylobacter Infection and Guillain-Barré Syndrome in Bangladesh: Clinical Epidemiology and Comparative Microbial Genomics. Available online:  http://hdl.handle.net/1765/78268.</Citation></Reference><Reference><Citation>Arriaga-Nieto L., Hernández-Bautista P.F., Vallejos-Parás A., Grajales-Muñiz C., Rojas-Mendoza T., Cabrera-Gaytán D.A., Grijalva-Otero I., Cacho-Díaz B., Jaimes-Betancourt L., Padilla-Velazquez R., et al. Predict the Incidence of Guillain Barré Syndrome and Arbovirus Infection in Mexico, 2014–2019. PLoS Glob. Public Health. 2022;2:e0000137. doi: 10.1371/journal.pgph.0000137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0000137</ArticleId><ArticleId IdType="pmc">PMC10022261</ArticleId><ArticleId IdType="pubmed">36962143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>